Astrazeneca

FromAstraZeneca ([email protected])
Subject (43)Enhertu approved in the US for HER2-low mBC
Preheader (113)Enhertu approved in the US as the first HER2-directed therapy for patients with HER2-low metastatic breast cancer
Typography
Arial
Colors
Text Analysis
Body Words227
Subject Words8
Body Emojis1
Subject Emojis
Media Analysis
Text Links8
Image Links4
Total Links12
Images7
Technical Metrics
Performance
HTML Size, Kb
Pixel Length, px788 px
X-Spam Score-4.6
Preheader OptimizedNo
Timing
Day of WeekWednesday
TimeEvening

Enhertu approved in the US for HER2-low mBC

Enhertu approved in the US as the first HER2-directed therapy for patients with HER2-low metastatic breast cancer
Enhertu approved in the US for HER2-low mBC